Deletion Syndrome : Clinical and Molecular Analysis Using Array CGH

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Interstitial 22q13 deletions: genes other than SHANK3 have major effects on cognitive and language development

  2008cited by this paper
• Identification of chromosome abnormalities in subtelomeric regions by microarray analysis: A study of 5,380 cases

  2008cited by this paper
• Neurobehavioral Profile and Brain Imaging Study of the 22q13.3 Deletion Syndrome in Childhood

  2008cited by this paper
• 22q13.3 deletion syndrome: A recognizable malformation syndrome associated with marked speech and language delay

  2007influential reference
• Contribution of SHANK3 mutations to autism spectrum disorder.

  2007influential reference
• Chromosomal microarray analysis (CMA) detects a large X chromosome deletion including FMR1, FMR2, and IDS in a female patient with mental retardation

  2007cited by this paper
• Clinical Implementation of Chromosomal Microarray Analysis: Summary of 2513 Postnatal Cases

  2007cited by this paper
• Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders

  2006cited by this paper
• Deletion 22q13 Syndrome (Phelan-McDermid Syndrome)

  2005influential reference
• Epigenome analyses using BAC microarrays identify evolutionary conservation of tissue-specific methylation of SHANK3

  2005cited by this paper
• Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13.3 deletion syndrome

  2005cited by this paper
• Molecular and phenotypic characterization of ring chromosome 22

  2005cited by this paper
• Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism

  2003cited by this paper
• Synapse signalling complexes and networks: machines underlying cognition.

  2003cited by this paper
• Telomeric 22q13 deletions resulting from rings, simple deletions, and translocations: cytogenetic, molecular, and clinical analyses of 32 new observations

  2003cited by this paper
• Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms

  2003cited by this paper
• FISH-mapping of a 100-kb terminal 22q13 deletion

  2002cited by this paper
• 22q13 deletion syndrome.

  2001cited by this paper
• Regulation of dendritic spine morphology and synaptic function by Shank and Homer.

  2001cited by this paper
• Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome.

  2001cited by this paper
• 用水稻细菌人工染色体（Bacterial Artificial Chromosome）构建物理图谱

  2001influential reference
• Case with autistic syndrome and chromosome 22q13.3 deletion detected by FISH.

  2000cited by this paper
• The Shank family of scaffold proteins.

  2000cited by this paper
• Cryptic terminal rearrangement of chromosome 22q13.32 detected by FISH in two unrelated patients.

  1997cited by this paper
• Phenotypic correlations in patients with ring chromosome 22

  1977cited by this paper

• Phelan-McDermid Syndrome in Spanish children: gastrointestinal manifestations in relation to nutritional intake

  2025cites this paper
• Phenotypic variation in neural sensory processing by deletion size, age, and sex in Phelan-McDermid syndrome

  2025cites this paper
• Exploring the Landscape of Pre- and Post-Synaptic Pediatric Disorders with Epilepsy: A Narrative Review on Molecular Mechanisms Involved

  2024cites this paper
• Clinical, developmental and serotonemia phenotyping of a sample of 70 Italian patients with Phelan-McDermid Syndrome

  2024influential citation
• Definition and clinical variability of SHANK3-related Phelan-McDermid syndrome.

  2023cites this paper
• Gait Abnormalities in Children with Phelan-McDermid Syndrome

  2023cites this paper
• [Phelan-McDermid syndrome associated with a novel heterozygous mutation in the SHANK3 gene].

  2023cites this paper
• Updated consensus guidelines on the management of Phelan–McDermid syndrome

  2023cites this paper
• Consensus recommendations on lymphedema in Phelan-McDermid syndrome.

  2023cites this paper
• Descriptive Analysis of Adaptive Behavior in Phelan–McDermid Syndrome and Autism Spectrum Disorder

  2022cites this paper
• Variability in Phelan-McDermid Syndrome in a Cohort of 210 Individuals

  2022cites this paper
• Genetic and metabolic profiling of individuals with Phelan‐McDermid syndrome presenting with seizures

  2021cites this paper
• DELETION 22q13 SYNDROME

  2021cites this paper
• Comparison of SHANK3 deficiency in animal models: phenotypes, treatment strategies, and translational implications

  2021cites this paper
• Stressed parents, happy parents. An assessment of parenting stress and family quality of life in families with a child with Phelan-McDermid syndrome.

  2021cites this paper
• The Neurological Manifestations of Phelan-McDermid Syndrome.

  2021cites this paper
• Genotype–phenotype correlation in Phelan‐McDermid syndrome: A comprehensive review of chromosome 22q13 deleted genes

  2021cites this paper
• Strong evidence for genotype–phenotype correlations in Phelan-McDermid syndrome: results from the developmental synaptopathies consortium

  2021cites this paper
• Social Deficits and Repetitive Behaviors Are Improved by Early Postnatal Low-Dose VPA Intervention in a Novel shank3-Deficient Zebrafish Model

  2021cites this paper
• Angelman Syndrome and Angelman-like Syndromes Share the Same Calcium-Related Gene Signatures

  2021cites this paper
• Cerebral organoids as tools to identify the developmental roots of autism

  2020cites this paper
• Recent developments in Phelan-McDermid syndrome research: an update on cognitive development, communication and psychiatric disorders.

  2020cites this paper
• A 29 Mainland Chinese cohort of patients with Phelan–McDermid syndrome: genotype–phenotype correlations and the role of SHANK3 haploinsufficiency in the important phenotypes

  2020cites this paper
• Bringing everyone to the table – findings from the 2018 Phelan-McDermid Syndrome Foundation International Conference

  2020cites this paper
• Diagnosis of metachromatic leukodystrophy in a patient with regression and Phelan-McDermid syndrome.

  2020cites this paper
• Psychiatric illness and regression in individuals with Phelan-McDermid syndrome

  2020cites this paper
• Caracterização genótipo-fenótipo em novas síndromes associadas ao Transtorno do Espectro Autista

  2019cites this paper
• First-Tier Array CGH in Clinically Variable Entity Diagnosis: 22q13.3 Deletion Syndrome

  2019cites this paper
• Functional genomics analysis of Phelan-McDermid syndrome 22q13 region during human neurodevelopment

  2019cites this paper
• Deep Phenotyping of Development, Communication and Behaviour in Phelan-McDermid Syndrome

  2019influential citation
• A Brazilian cohort of individuals with Phelan-McDermid syndrome: genotype-phenotype correlation and identification of an atypical case

  2019cites this paper
• PDZ Domains as Drug Targets

  2019cites this paper
• Apparent Genetic Rescue of Adult Shank3 Exon 21 Insertion Mutation Mice Tempered by Appropriate Control Experiments

  2019cites this paper
• Novel applications of array comparative genomic hybridization in molecular diagnostics

  2018cites this paper
• Behavioral Phenotyping of an Improved Mouse Model of Phelan–McDermid Syndrome with a Complete Deletion of the Shank3 Gene

  2018cites this paper
• 22q13 deletion syndrome: communication disorder or autism? Evidence from a specific clinical and neurophysiological phenotype

  2018cites this paper
• Prospective longitudinal overnight video-EEG evaluation in Phelan-McDermid Syndrome.

  2018cites this paper
• Framework for assessing individuals with rare genetic disorders associated with profound intellectual and multiple disabilities (PIMD): the example of Phelan McDermid Syndrome

  2018cites this paper
• Identification of 22q13 genes most likely to contribute to Phelan McDermid syndrome

  2018cites this paper
• Artigo OriginalGenomic imbalances in syndromic congenital heart diseaseDesequilíbrios genômicos na cardiopatia congênita sindrômica

  2017cites this paper
• Autismo: importancia de la dismorfología en la identificación de entidades médicas asociadas

  2017cites this paper
• Array-Comparative Genomic Hybridization/Microarray Analysis: Interpretation of Copy Number Variants

  2017cites this paper
• A framework to identify contributing genes in patients with Phelan-McDermid syndrome

  2017cites this paper
• A framework to identify modifier genes in patients with Phelan-McDermid syndrome

  2017cites this paper
• Characterizing regression in Phelan McDermid Syndrome (22q13 deletion syndrome).

  2017influential citation
• Genomic imbalances in syndromic congenital heart disease.

  2017cites this paper
• Clinical and molecular characterization of three genomic rearrangements at chromosome 22q13.3 associated with autism spectrum disorder

  2017cites this paper
• Positive modulation of mGlu5 reverses ASD-like behaviors found in SHANK3 knock-out mice

  2016influential citation
• 16p11.2 deletion and duplication: Characterizing neurologic phenotypes in a large clinically ascertained cohort

  2016cites this paper
• Clinical and genomic evaluation of a Chinese patient with a novel deletion associated with Phelan–McDermid syndrome

  2016cites this paper
• Neural selectivity for communicative auditory signals in Phelan-McDermid syndrome

  2016cites this paper
• Caracterización clínica de pacientes con diagnóstico de trastorno del espectro autista en el Hospital Militar Central e Instituto De Ortopedia Infantil Roosevelt, de enero 2010 a enero de 2014

  2016cites this paper
• Neuropsychological phenotype and psychopathology in seven adult patients with Phelan‐McDermid syndrome: implications for treatment strategy

  2016cites this paper
• The spectrum of epilepsy and electroencephalographic abnormalities due to SHANK3 loss‐of‐function mutations

  2016cites this paper
• Concomitant 11p15.4‐p15.5 duplication and terminal 22q13.33 deletion in a patient with features of Beckwith–Wiedemann syndrome

  2016cites this paper
• Genes with high penetrance for syndromic and non-syndromic autism typically function within the nucleus and regulate gene expression

  2016cites this paper
• Angelman-Like Syndrome: A Genetic Approach to Diagnosis with Illustrative Cases

  2016cites this paper
• Genomic Microarray in Intellectual Disability: The Usefulness of Existing Systems in the Interpretation of Copy Number Variation

  2016cites this paper
• Phelan–McDermid Syndrome: Clinical Aspects

  2016cites this paper
• Synapse Dysfunction Induced by Autism Spectrum Disorder Associated Shank3 Mutations

  2015cites this paper
• Phelan–McDermid Syndrome and SHANK3: Implications for Treatment

  2015influential citation
• Ultrastructural analyses in the hippocampus CA1 field in Shank3-deficient mice

  2015cites this paper
• The deletion 22q13 syndrome: a new case.

  2015cites this paper
• Concise Review: Exciting Cells: Modeling Genetic Epilepsies with Patient‐Derived Induced Pluripotent Stem Cells

  2015cites this paper
• Phelan McDermid Syndrome

  2015cites this paper
• Synaptic proteins and receptors defects in autism spectrum disorders

  2014cites this paper
• Phelan-McDermid syndrome: a review of the literature and practice parameters for medical assessment and monitoring

  2014cites this paper
• Clinical and genomic evaluation of 201 patients with Phelan–McDermid syndrome

  2014cites this paper
• A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome

  2014cites this paper
• A patient with the classic features of Phelan‐McDermid syndrome and a high immunoglobulin E level caused by a cryptic interstitial 0.72‐Mb deletion in the 22q13.2 region

  2014cites this paper
• Absence of strong strain effects in behavioral analyses of Shank3-deficient mice

  2014cites this paper
• Epigenetic dysregulation of SHANK3 in brain tissues from individuals with autism spectrum disorders.

  2014cites this paper
• If not Angelman, what is it? a review of Angelman‐like syndromes

  2014cites this paper
• Clinical, cytogenetic, and molecular characterization of six patients with ring chromosomes 22, including one with concomitant 22q11.2 deletion

  2014cites this paper
• Repetitive behaviors in the Shank1 knockout mouse model for autism spectrum disorder: developmental aspects and effects of social context.

  2014cites this paper
• Seizures and EEG features in 74 patients with genetic‐dysmorphic syndromes

  2014cites this paper
• Reciprocal signaling between translational control pathways and synaptic proteins in autism spectrum disorders

  2014cites this paper
• Ultrasonic vocalizations in Shank mouse models for autism spectrum disorders: detailed spectrographic analyses and developmental profiles.

  2014cites this paper
• Chromosomal microarray analysis of consecutive individuals with autism spectrum disorders or learning disability presenting for genetic services.

  2014cites this paper
• Pathogenic chromosomal microarray copy number changes by chromosome order

  2014cites this paper
• Human and Primate Subtelomeres

  2014cites this paper
• Epigenetic dysregulation of SHANK 3 in brain tissues from individuals with autism spectrum disorders

  2014cites this paper
• Subtelomeres

  2014cites this paper
• Genomic Designation: New kinds of people at the intersection of genetics, medicine and social action

  2013cites this paper
• Novel treatments in autism spectrum disorders: from synaptic dysfunction to experimental therapeutics.

  2013cites this paper
• Autism spectrum disorders: The quest for genetic syndromes

  2013cites this paper
• 22q13.2q13.32 genomic regions associated with severity of speech delay, developmental delay, and physical features in Phelan–McDermid syndrome

  2013cites this paper
• Phelan–McDermid syndrome: Clinical report of a 70‐year‐old woman

  2013cites this paper
• SHANK2 and SHANK3 Mutations Implicate Glutamate Signaling Abnormalities in Autism Spectrum Disorders

  2013cites this paper
• Copy number variants in adult patients with Lennox-Gastaut syndrome features.

  2013cites this paper
• Deletion of the last exon of SHANK3 gene produces the full Phelan-McDermid phenotype: a case report.

  2013influential citation
• Novi mikrodelecijski sindromi

  2013cites this paper
• Autism spectrum disorder in the genetics clinic: a review

  2013cites this paper
• Modeling autism by SHANK gene mutations in mice.

  2013cites this paper
• Cerebellar and posterior fossa malformations in patients with autism‐associated chromosome 22q13 terminal deletion

  2013cites this paper
• Prospective investigation of autism and genotype-phenotype correlations in 22q13 deletion syndrome and SHANK3 deficiency

  2013influential citation
• LossofPredominantShank3IsoformsResultsin Hippocampus-DependentImpairmentsinBehaviorand SynapticTransmission

  2013cites this paper
• An epigenetic framework for neurodevelopmental disorders: from pathogenesis to potential therapy.

  2013cites this paper
• Chapter 34 – Autisms

  2013cites this paper
• Loss of Predominant Shank3 Isoforms Results in Hippocampus-Dependent Impairments in Behavior and Synaptic Transmission

  2013cites this paper